ArticleBMC pregnancy and childbirth2025
Prediction of preeclampsia by evaluating the RI of placental second villi in the third trimester with HR-Flow ultrasound.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo investigate the value of predicting preeclampsia (PE) using high resolution flow (HR-Flow) ultrasound to evaluate the resistance index (RI) of placental second villi in the third trimester.
methodsA total of 103 singleton pregnancies with follow-up results undergoing HR-Flow imaging of the placenta during the third trimester in the affiliated Yixing Hospital of Jiangsu University were recruited in this prospective cohort study from August 2021 to July 2023. Doppler resistance index values of the placental second villi were measured. Based on the clinical manifestations, the patients were divided into three groups: control (n = 78), hypertension (n = 11), and PE (n = 14). The performance of the second villous RI in predicting PE was analyzed using a receiver operating characteristic (ROC) curve.
resultsThe PE group had a significantly higher rate of poor placental perfusion than the control and hypertension groups (P < 0.001, 0.048). The second villous RI values of the control, hypertension, and PE groups were 0.42 ± 0.10, 0.47 ± 0.07, 0.49 ± 0.06, respectively, with statistically significant differences among the three groups (P = 0.017). The area under the ROC curve for predicting PE was 0.734, the optimal cut off value was 0.50, and the sensitivity and specificity were 0.643 and 0.809, respectively.
conclusionThe optimal cut-off value of placental second villous RI may be a potential evaluation parameter for predicting PE, and is worthy of further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.